BioSpace News Archive

Bone Densitometers Market to Reach USD 1.11 Bn By 2024, Rising incidence of osteoporosis condition in post-menopausal women to drive the market

Albany NY, United States: The increasing number of bone density disorders especially among the geriatric population is projected to aid in the expansion of the bone densitometers market.

March 14, 2022
·
6 min read
Bariatric Surgery Devices Market is Expected to Touch US$1.74 Bn by 2025, Increasing Sedentary Lifestyle and Growing Prevalence of Obesity to Drive the Market

Albany NY, United States: The global bariatric surgical devices market is anticipated to experience high competition among the players, observes Transparency Market Research.

March 14, 2022
·
4 min read
Veterinary Hematology Analyzers Market is Projected to Rise to US$1,178.9 Mn by 2024, Increase in Demand for Modern Pet Healthcare Facilities to Drive the Market

Albany NY, United States: The global veterinary hematology analyzers displays a highly competitive market landscape with a few prominent players holding more than 50 percent of the market’s share, reports Transparency Market Research.

March 14, 2022
·
5 min read
Expansion of Everest Medicine’s licence agreement to include South Korea

Calliditas Therapeutics AB announced that the company has expanded its licensing agreement with Everest Medicines II Limited to extend the territory covered to include South Korea.

March 14, 2022
·
4 min read
Policy

SIFI Announces the Granting of a Second FDA Orphan Drug Designation for Polihexanide in Fungal Keratitis

SIFI S.p.A., a leading international ophthalmic pharmaceutical company, announced that the U.S. Food and Drug Administration has approved the company’s Orphan Drug Designation application for its investigational anti-infective polymer polihexanide for the treatment of fungal keratitis.

March 14, 2022
·
4 min read
Business

BrainStorm to Announce Fourth Quarter and Fiscal Year 2021 Financial Results and Provide a Corporate Update

BrainStorm Cell Therapeutics Inc. announced that the Company will hold a conference call to update shareholders on financial results for the fourth quarter and year ended December 31, 2021, and provide a corporate update, at 8:00 a.m. Eastern Time on Monday, March 28, 2022.

March 14, 2022
·
5 min read
Business

Biodesix Announces Fourth Quarter and Year End 2021 Results and Highlights

Biodesix, Inc., a leading data-driven diagnostic solutions company with a focus in lung disease, announced its financial and operating results for the fourth quarter and year ended December 31, 2021 and provided a corporate update.

March 14, 2022
·
9 min read
FDA

Shoulder Innovations Announces FDA Clearance of New InSet™ Stemless Humeral Implant

Shoulder Innovations Inc. announces the FDA Clearance of their latest component of the InSet™ Total Shoulder System, the InSet™ Stemless Humeral System.

March 14, 2022
·
3 min read
Bright Minds Biosciences Announces Successful Completion of 28-Day Toxicology Studies and Advancement to First-in-Human Clinical Trial

Bright Minds Biosciences, a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders, epilepsy, and pain, announced the successful completion of 28-day repeat-dose toxicity studies for its lead product, BMB-101.

March 14, 2022
·
4 min read
Business

Evaxion Biotech Strengthens Management Team with Two Senior Appointments

Evaxion Biotech A/S is a clinical-stage biotechnological company specializing in the development of AI-powered immunotherapies to improve the lives of patients with cancer and infectious diseases.

March 14, 2022
·
5 min read